Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Pathogenesis of cardiovascular disease in HIV infection.

Carr A.

Curr Opin HIV AIDS. 2008 May;3(3):234-9. doi: 10.1097/COH.0b013e3282fb7be0.

PMID:
19372972
2.

Diagnosis and management of common chronic metabolic complications in HIV-infected patients.

Bader MS, Kelly DV.

Postgrad Med. 2008 Nov;120(4):17-27. doi: 10.3810/pgm.2008.11.1930. Review.

PMID:
19020362
3.

Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.

De Lorenzo F, Collot-Teixeira S, Boffito M, Feher M, Gazzard B, McGregor JL.

Curr Med Chem. 2008;15(28):2991-9. Review.

PMID:
19075647
4.

Insulin Resistance and the cardiometabolic syndrome in HIV infection.

Bevilacqua M, Dominguez LJ, Barbagallo M.

J Cardiometab Syndr. 2009 Winter;4(1):40-3. doi: 10.1111/j.1559-4572.2008.00027.x. Review.

PMID:
19245515
5.

Update on cardiovascular complications in HIV infection.

Currier JS.

Top HIV Med. 2009 Jul-Aug;17(3):98-103. Review.

6.

Clinical management of HIV-associated lipodystrophy.

Pirmohamed M.

Curr Opin Lipidol. 2009 Aug;20(4):309-14. doi: 10.1097/MOL.0b013e32832d3bb1. Review.

PMID:
19494771
7.

How HIV protease inhibitors promote atherosclerotic lesion formation.

Thomas CM, Smart EJ.

Curr Opin Lipidol. 2007 Oct;18(5):561-5. Review.

PMID:
17885428
8.

NeuroAIDS: an evolving epidemic.

Power C, Boissé L, Rourke S, Gill MJ.

Can J Neurol Sci. 2009 May;36(3):285-95. Review.

PMID:
19534327
9.

Improvements in antiretroviral therapy outcomes over calendar time.

Boyd MA.

Curr Opin HIV AIDS. 2009 May;4(3):194-9. doi: 10.1097/COH.0b013e328329fc8d. Review.

PMID:
19532050
10.

Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Szczech LA.

Curr Opin HIV AIDS. 2009 May;4(3):167-70. doi: 10.1097/COH.0b013e328329c646. Review.

PMID:
19532045

Supplemental Content

Support Center